Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Dynavax completes patient enrollment and dosing in phase I ragweed allergy trial

Aug. 24, 1999

Xoma and Genentech expand hu1124 collaboration to include transplantation

Aug. 23, 1999

Known anti-HIV compound also shows potential in treating immune disorders

Aug. 20, 1999

SangStat's cold storage solution for donor hearts cleared by FDA

Aug. 19, 1999

New transplant agent marketed by Roche in U.K.

Aug. 18, 1999

Isotechnika advances development of new immunosuppressant

Aug. 17, 1999

Cangene receives notification of fast-track status for new anti-chickenpox product

Aug. 16, 1999

AdProTech reaches C3d adjuvant licensing agreement with University of Cambridge

Aug. 16, 1999

CpG ImmunoPharmaceuticals obtains financing for additional clinical trials

Aug. 16, 1999

Aviron's EBV vaccine completes phase I trial

Aug. 13, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...